Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
GILD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.80%61.580.0%$914.89m
NVAXNovavax, Inc. -5.99%98.30102.0%$790.47m
AMGNAmgen, Inc. -0.62%251.591.3%$725.25m
REGNRegeneron Pharmaceuticals, Inc. -0.08%640.342.5%$677.64m
GILDGilead Sciences, Inc. -1.06%75.611.0%$627.17m
BIIBBiogen, Inc. 4.41%280.191.6%$622.60m
VRTXVertex Pharmaceuticals, Inc. -1.05%295.921.9%$509.00m
ILMNIllumina, Inc. -0.61%369.873.5%$300.06m
ALXNAlexion Pharmaceuticals, Inc. -3.97%108.002.0%$219.47m
BMRNBioMarin Pharmaceutical, Inc. 0.59%128.734.3%$214.30m
SGENSeattle Genetics, Inc. -0.35%175.536.1%$200.21m
SRNESorrento Therapeutics, Inc. -1.22%7.291.8%$180.15m
IMMUImmunomedics, Inc. 0.95%41.5511.0%$179.47m
SRPTSarepta Therapeutics, Inc. 3.82%170.1513.9%$164.96m
ALNYAlnylam Pharmaceuticals, Inc. 0.26%160.428.5%$164.06m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.